Abstract Submission

Before submitting your abstract, you are entitled to read the following carefully:

• Abstract submission starts from March, 2024, and all abstracts must be submitted before 11:59 pm on June 14th, 2024.
• The work described in the abstract must not have been published or presented (in manuscript or abstract form) elsewhere before submission to Jogja Urology Forum 2024.
• Abstracts must be in English and should be uploaded through our website.
• For clinical studies, authors must confirm that they have obtained appropriate ethical clearance prior to conducting the study.
• Only one author may submit an abstract.
• Abstracts must be written and presented in good English. Authors are not allowed to revise a submission after it has been accepted. The Scientific Committee reserves the right to reject or request immediate revision of submissions presented with poor English.
• Acceptance of a submission is based on the scores given by at least 2 reviewers.
• Authors will be informed about the status of their submission via email on July 15th, 2024.
• The acceptance process is considered finished after payment of the conference fee.
• Abstracts cannot be revised or resubmitted after submission.

• Abstracts of original research papers, case reports, review articles (systematic review and metaanalysis) will be accepted.
• Original research and review must consist of 5 parts: Introduction, Aim, Materials and Methods, Results, and Conclusion.
• Case reports must consist of 3 parts: Introduction, Case Reports, and Conclusion.
• Abstracts must not be longer than 2500 characters. Title and internal titles (Introduction, Aim, etc) are not included.
• Abstracts are not allowed to contain grids, graphs, and picture images.
• Systematic reviews (with or without meta-analysis) can be submitted if they meet the following standards:
• • Using the standard PICO format (Population, Intervention, Comparison, and Outcome) to define Clinical questions
  • Performed comprehensive systematic literature search
  • Risk assessment of the risk of bias was carried out
  • Key findings are clearly described including clinical practice relevance